KGI Research Singapore

Singapore's leading broker offering Futures, FX, Equities and Wealth Management.

Jiutian Chemical Group (JIUC SP/JUTN.SI)

Company Update: 17 May 2022

Expecting another record year in FY22

  • Jiutian reported a record-high profit in 1Q22, mainly driven by the surge in the average selling prices (ASP). The ASP of DMF and methylamine jumped by 73.0% YoY and 116.3% YoY respectively during the period.
  • Global energy prices surged in 1Q22, driven by the Russia-Ukraine conflicts and then ensuing sanctions on Russia. Higher energy prices provided solid support for chemical prices.  However, China’s zero-covid policy resulted in supply chain disruptions, dragging down sales volumes.  
  • 2H22 chemicals sector is expected to remain stable. China’s expansionary monetary and fiscal policy will uphold the rebound of economic growth.
  • FY22F PATMI were adjusted upward by 183.2% to RMB541mn due mainly to the jump in average selling prices of the product mix and the prolonged duration of the upcycle. Based on a reasonable PE of 4.5x and the FY22F ESP of RMB0.27, we maintained our OUTPERFORM rating and raised our TP to 0.245 SG cents, implying an upside of 150% from the last closing price of S$0.098.

A record-high profit in 1Q22 driven by skyrocketed average selling prices

Jiutian Chemical group (Jiutian) continued to deliver strong earnings in 1Q22 due mainly to the jump in average selling prices of both DMF and methylamine. However, the respective sales volume of DMF and methylamine dropped by 26% YoY and 20 % YoY due mainly to the government-imposed lockdown measures in Anyang City. The China domestic average DMF price surged by 78% YoY to RMB16,000/tonne. 

Valuation & Action

We revised upward our FY22F/23F revenue by 77.4%/44.4% to RMB2,475mn/RMB1,950mn. Accordingly, FY22F/23F PATMI were adjusted upward by 183.2%/72.7% to RMB541mn/RMB320mn. The adjustments are due mainly to the jump in average selling prices of the product mix and the prolonged duration of the upcycle.

The average forward PE of Jiutian’s peers listed in China is 7.4x, and the forward PE of its peer listed in Singapore is 4.1x. Hence, based on a reasonable PE of 4.5x and the FY22F ESP of RMB0.27, we maintained our OUTPERFORM rating and raised our TP to 0.245 SG cents, implying an upside of 150% from the last closing price of S$0.098.

Risks

Decline in ASP of its two main products, DMF and methylamine, is a key risk to earnings.

Tailwinds of the unexpected geopolitical eventtion & Action

During the period, geopolitical risks surged to an unprecedented level after World War II owing to the military conflicts between Russia and Ukraine. The ensuing sanctions on Russia sent global energy prices to a decade high. Both Brent and WTI stayed elevated at above US$100/bbl. Meanwhile, coal prices remained buoyant. The thermal coal price averaged at RMB817/tonne, up 16% YoY in 1Q22. The skyrocketing energy prices provided solid support for chemical prices as chemical products are derivatives of crude oil and coal.

Headwinds of the China zero-covid policy

The Omicron outbreak in China’s major cities has triggered the most draconian subsequent lockdowns for nearly two months. The supply chain disruptions such as production halts and logistics interruptions drag the trade flows/volumes. However, these benefit chemical prices as the mark-ups of transportation and raw materials costs result in the uptick in quotes. Based on last two years track record, the gain in the ASP is much more than the loss in sales volumes.     

2H22 outlook to remain stable

In the near term, China will continue to persist in its zero-covid policy which stifles economic growth. However, China started to carry out the counter-cycle monetary policies by lowering the loan prime rate and required rate of reserve in 1Q22. Meanwhile, the National Development and Reform Commission is drafting a US$2.3tn infrastructure plan. Moving forward, the expansionary fiscal and monetary policies will uphold the rebound of the domestic economy in 2H22.     

Compelling valuation

Jiutian’s financial performance is comparable to the peers listed in Singapore and China. However, its current valuation is half of its peers’. As of 1Q22, the company’s net cash was RMB718.1mn, equivalent to S$147.5mn, accounting for 75.7% of the current market cap. Recently, the compare declared an interim dividend of 0.75 SG cents, implying a dividend yield of 7.6% as of the last closing price of 9.8 SG cents.   


Subscribe Now